CTI BioPharma Corp. (CTIC): Price and Financial Metrics
CTI BioPharma Corp. (CTIC)
Today's Latest Price: $1.05 USD
Updated Sep 25 4:00pm
Add CTIC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CTIC Stock Summary
- CTIC's price/sales ratio is 33.82; that's higher than the P/S ratio of 94.87% of US stocks.
- As for revenue growth, note that CTIC's revenue has grown -85.92% over the past 12 months; that beats the revenue growth of only 1.44% of US companies in our set.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CTIC comes in at -69.52% -- higher than that of just 6.39% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Cti Biopharma Corp, a group of peers worth examining would be HTBX, EPZM, VXRT, QUIK, and PSNL.
- Visit CTIC's SEC page to see the company's official filings. To visit the company's web site, go to www.ctibiopharma.com.
CTIC Stock Price Chart Technical Analysis Charts
CTIC Price/Volume Stats
| Current price | $1.05 | 52-week high | $1.95 |
| Prev. close | $1.03 | 52-week low | $0.62 |
| Day low | $1.00 | Volume | 77,276 |
| Day high | $1.05 | Avg. volume | 432,183 |
| 50-day MA | $1.26 | Dividend yield | N/A |
| 200-day MA | $1.18 | Market Cap | 77.40M |
CTI BioPharma Corp. (CTIC) Company Bio
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company was founded in 1991 and is based in Seattle, Washington.
Loading social stream, please wait...